William P. Quinn

CIK 1724190 · President, CEO and CFO · last filed 2026-02-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.5K

Companies

2

Total Filings

18

Lifetime Open-Market Net

$108.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BOLT President, CEO and CFO 2,313 $4.56 $10.5K $83.4K 12 2026-02-04
Viracta Therapeutics, Inc. (SNSS) Delisted See Remarks 127,697 $18.62 $2.38M $24.9K 6 2020-04-02

Recent Filings · Page 2 of 2

18 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-02-09 BOLT Buy (P) +1,200 $24.0K EDGAR
2021-02-08 BOLT Grant (A) $0 EDGAR
2020-04-02 Viracta Therapeutics, Inc. (SNSS) Delisted Mixed +12,000 $6.1K EDGAR
2019-04-01 Viracta Therapeutics, Inc. (SNSS) Delisted Grant (A) $0 EDGAR
2019-03-04 Viracta Therapeutics, Inc. (SNSS) Delisted Grant (A) +63,697 $0 EDGAR
2019-01-03 Viracta Therapeutics, Inc. (SNSS) Delisted Grant (A) $0 EDGAR
2018-12-12 Viracta Therapeutics, Inc. (SNSS) Delisted Buy (P) +40,000 $18.8K EDGAR
2017-12-04 Viracta Therapeutics, Inc. (SNSS) Delisted Grant (A) $0 EDGAR
Showing 1118 of 18
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.